Integras Partners’s Bristol-Myers Squibb BMY Stock Holding History

Integras Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.43M	Buy	59,474 +890	+2%	+$51.1K	1.89%	19
2026 Q1	$3.55M	Sell	58,584 -756	-1%	-$44.1K	2.33%	10
2025 Q4	$3.2M	Sell	59,340 -10,940	-16%	-$526K	2.59%	14
2025 Q3	$3.17M	Buy	70,280 +22,141	+46%	+$1.03M	2.56%	12
2025 Q2	$2.23M	Sell	48,139 -421	-0.9%	-$20.7K	2.24%	26
2025 Q1	$2.96M	Sell	48,560 -513	-1%	-$29.9K	2.67%	11
2024 Q4	$2.78M	Buy	+49,073	New	+$2.74M	2.37%	15

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Integras Partners's BMY Position: Q2 2026 in Review

Integras Partners increased its Bristol-Myers Squibb (BMY) stake by 1.5% in Q2 2026, buying an estimated $51.1K and bringing the position to 59,474 shares worth $3.43M. The position accounts for 1.89% of the portfolio, ranked #19.

Integras Partners first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.55M in Q1 2026. 874 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Integras Partners held 59,474 shares of Bristol-Myers Squibb worth $3.43M as of Q2 2026.
Integras Partners bought 890 Bristol-Myers Squibb shares in Q2 2026, an estimated $51.1K.
Bristol-Myers Squibb made up 1.89% of Integras Partners's portfolio in Q2 2026, its #19 holding.
Integras Partners first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Integras Partners's Bristol-Myers Squibb position peaked at $3.55M in Q1 2026.
874 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Integras Partners's 13F filing for Q2 2026, filed 24 Jul 2026.